Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.

Psoriatic arthritis (PsA) develops in four stages: the preclinical stage, where those with psoriasis (PsO) are at higher risk but have no symptoms; the subclinical stage, where inflammation is ...

Within immunology, we saw sales growth in TREMFYA of 5.6%, driven by strong market growth and share gains in PsO and PsA ... In psoriasis and psoriatic arthritis, but really particularly with ...

Results from the POETYK PSO-1 and POETYK PSO-2 showed that 58% and 53% respectively of patients treated with Sotyktu achieved 75% skin clearance, versus 35% and 40% for Otezla. BMS has set a list ...

Introduction: To verify our hypothesis that psoriatic arthritis (PsA) is mainly genetically predetermined and distinct from psoriasis (PsO), we use the TriNetX database to investigate whether ...

4 In their recent work, Singla et al5 performed a post hoc analysis of data from PsO patients who were treated with different types of biological immunotherapy, with a focus on the time to onset of ...

Volunteers had no personal history of any rheumatic disease, PsO, inflammatory bowel disease, active malignancy or chronic infection. Patients with early and treatment-naïve rheumatoid arthritis (RA) ...

8.1%), psoriatic arthritis/psoriasis (PsA/PsO) (76, 5.0%), primary Sjogren’s syndrome (74, 4.9%) and ankylosing spondylitis (44, 2.9%) (online supplemental figure 2). Among all participants, 450/1507 ...

OKLAHOMA CITY — Public Service Company of Oklahoma customers will see a temporary rate increase that was adopted last year made permanent following action Wednesday by the Oklahoma Corporation ...

Arthritis is a condition that causes inflammation and pain in your joints. It can be caused by the wear and tear of normal aging or by an autoimmune condition that attacks the cells in your joints ...